Results 161 to 170 of about 164,460 (261)
What counts as public health expenditures? A comparative case study of Australia, Canada, and England. [PDF]
Seabrook MSS +4 more
europepmc +1 more source
Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon +5 more
wiley +1 more source
The changing Part D landscape. [PDF]
Joyce G, Chen B, Blaylock B.
europepmc +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Pacific-Led Responses to COVID-19: Lessons for Future Pandemic Preparedness. [PDF]
Matenga-Ikihele A +5 more
europepmc +1 more source
ABSTRACT Objectives We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance.
Christine Lebrun‐Frenay +13 more
wiley +1 more source
Transforming health systems in Tanzania towards universal health coverage: a scoping review of policy evolution, 1961-2025. [PDF]
Kiremeji M +14 more
europepmc +1 more source
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
Related to T4.3. Report on data governance within the CIP platform with the description of the support process in allowing the data valorization and incorporating privacy and ethical issues.
openaire +1 more source
Evolving national dementia policies in the OECD: Prevention, diagnosis, and care. [PDF]
Kim S +4 more
europepmc +1 more source

